| Primary |
| Hiv Infection |
60.5% |
| Antiretroviral Therapy |
10.9% |
| Antiviral Prophylaxis |
5.1% |
| Prophylaxis Against Hiv Infection |
4.8% |
| Acquired Immunodeficiency Syndrome |
3.1% |
| Antiviral Treatment |
2.7% |
| Drug Use For Unknown Indication |
2.5% |
| Product Used For Unknown Indication |
2.0% |
| Prophylaxis |
1.5% |
| Tuberculosis |
1.4% |
| Hiv Test Positive |
1.3% |
| Human Immunodeficiency Virus Transmission |
0.9% |
| Pneumocystis Jiroveci Infection |
0.6% |
| Maternal Exposure During Pregnancy |
0.6% |
| Acute Hiv Infection |
0.6% |
| Foetal Exposure During Pregnancy |
0.4% |
| Diffuse Large B-cell Lymphoma |
0.3% |
| Malaria Prophylaxis |
0.3% |
| Pain |
0.3% |
| Encephalitis |
0.3% |
|
| Maternal Drugs Affecting Foetus |
11.8% |
| Vomiting |
10.8% |
| Drug Exposure During Pregnancy |
10.4% |
| Immune Reconstitution Syndrome |
9.2% |
| Ventricular Hypertrophy |
6.6% |
| Premature Baby |
6.4% |
| Stillbirth |
5.4% |
| Hypospadias |
5.0% |
| Neutropenia |
4.2% |
| Portal Hypertension |
3.8% |
| Pregnancy |
3.3% |
| Splenomegaly |
2.8% |
| Weight Decreased |
2.8% |
| Maternal Exposure During Pregnancy |
2.6% |
| Osteonecrosis |
2.6% |
| Progressive Multifocal Leukoencephalopathy |
2.6% |
| Pulmonary Hypertension |
2.6% |
| Pyrexia |
2.6% |
| Uveitis |
2.4% |
| Death |
2.1% |
|
| Secondary |
| Hiv Infection |
50.2% |
| Drug Exposure During Pregnancy |
8.3% |
| Human Immunodeficiency Virus Transmission |
8.3% |
| Prophylaxis |
7.5% |
| Antiretroviral Therapy |
6.4% |
| Prophylaxis Against Hiv Infection |
4.3% |
| Drug Use For Unknown Indication |
3.2% |
| Antiviral Prophylaxis |
2.5% |
| Product Used For Unknown Indication |
2.4% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Tuberculosis |
0.9% |
| Hiv Test Positive |
0.8% |
| Maternal Exposure During Pregnancy |
0.7% |
| Systemic Antiviral Treatment |
0.6% |
| Prophylaxis Against Transplant Rejection |
0.6% |
| Maternal Exposure Timing Unspecified |
0.6% |
| Antifungal Prophylaxis |
0.5% |
| Hepatitis C |
0.4% |
| Antiviral Treatment |
0.3% |
| Hypertension |
0.3% |
|
| Drug Exposure During Pregnancy |
11.8% |
| Premature Baby |
10.8% |
| Hiv Infection |
10.2% |
| Weight Decreased |
6.8% |
| Vomiting |
6.7% |
| Pregnancy |
5.7% |
| Progressive External Ophthalmoplegia |
5.7% |
| Stillbirth |
5.0% |
| Small For Dates Baby |
4.2% |
| Viral Mutation Identified |
3.9% |
| Ventricular Hypertrophy |
3.7% |
| Ventricular Septal Defect |
3.7% |
| Respiratory Distress |
3.1% |
| Neutropenia |
2.9% |
| Maternal Drugs Affecting Foetus |
2.8% |
| Death |
2.7% |
| Pyrexia |
2.7% |
| Sepsis |
2.6% |
| Death Neonatal |
2.5% |
| Deep Vein Thrombosis |
2.5% |
|
| Concomitant |
| Hiv Infection |
59.2% |
| Drug Use For Unknown Indication |
11.0% |
| Drug Exposure During Pregnancy |
6.1% |
| Product Used For Unknown Indication |
3.7% |
| Antiretroviral Therapy |
3.0% |
| Acquired Immunodeficiency Syndrome |
2.9% |
| Prophylaxis |
2.8% |
| Prophylaxis Against Hiv Infection |
2.1% |
| Mycobacterium Avium Complex Infection |
1.2% |
| Tuberculosis |
1.1% |
| Hiv Test Positive |
0.9% |
| Antiviral Prophylaxis |
0.9% |
| Diarrhoea |
0.8% |
| Antifungal Prophylaxis |
0.8% |
| Cytomegalovirus Infection |
0.7% |
| Pneumocystis Jiroveci Pneumonia |
0.6% |
| Maternal Exposure During Pregnancy |
0.6% |
| Vitamin Supplementation |
0.6% |
| Gestational Diabetes |
0.5% |
| Maternal Exposure Timing Unspecified |
0.5% |
|
| Vomiting |
19.6% |
| Death |
7.1% |
| Premature Baby |
6.6% |
| Weight Decreased |
5.7% |
| Pregnancy |
5.3% |
| Renal Failure |
5.1% |
| Pyrexia |
4.4% |
| Drug Exposure During Pregnancy |
4.2% |
| Umbilical Cord Abnormality |
4.2% |
| Renal Failure Acute |
4.0% |
| Neutropenia |
3.8% |
| Pneumonia |
3.8% |
| Abortion Spontaneous |
3.5% |
| Premature Labour |
3.5% |
| Rash |
3.3% |
| Suicidal Ideation |
3.3% |
| Upper Gastrointestinal Haemorrhage |
3.3% |
| Myositis |
3.1% |
| Pain In Extremity |
3.1% |
| Ultrasound Antenatal Screen Abnormal |
3.1% |
|
| Interacting |
| Hiv Infection |
36.6% |
| Antiretroviral Therapy |
32.5% |
| Product Used For Unknown Indication |
8.1% |
| Drug Use For Unknown Indication |
4.9% |
| Contraception |
4.1% |
| Neuropathy Peripheral |
2.4% |
| Alcohol Abuse |
1.6% |
| Antisocial Personality Disorder |
1.6% |
| Bronchospasm |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Convulsion |
0.8% |
| Hepatitis C |
0.8% |
| Hypertension |
0.8% |
| Insomnia |
0.8% |
| Pulmonary Embolism |
0.8% |
| Renal Transplant |
0.8% |
|
| Drug Interaction |
20.0% |
| Vomiting |
20.0% |
| Skin Striae |
8.0% |
| Amenorrhoea |
4.0% |
| Electrocardiogram Qt Corrected Interval Prolonged |
4.0% |
| Embolism Venous |
4.0% |
| Herpes Simplex |
4.0% |
| Incorrect Drug Administration Duration |
4.0% |
| Multi-organ Failure |
4.0% |
| Peroneal Nerve Palsy |
4.0% |
| Pigmentation Disorder |
4.0% |
| Pregnancy With Implant Contraceptive |
4.0% |
| Squamous Cell Carcinoma |
4.0% |
| Thrombocytopenia |
4.0% |
| Unintended Pregnancy |
4.0% |
| Viral Load Increased |
4.0% |
|
